Utility of lung ultrasound in assessing severity of interstitial lung diseases: correlation with high-resolution computed tomography and spirometry findings
Abstract
Interstitial lung diseases (ILDs) constitute a diverse category of diffuse parenchymal lung disorders whose diagnosis and monitoring are challenging due to complex clinic-radiological profiles and the risks of serial high-resolution computed tomography (HRCT). Lung ultrasound (LUS) has potential to become an easily available, non-ionizing substitute, though its comparative performance against HRCT and spirometry in severity assessment has been inadequately studied. We conducted a cross-sectional study of 52 adult ILD outpatients enrolled over one year, excluding those with cardiac failure, pulmonary tuberculosis, neoplasia, pregnancy, or acute ILD exacerbation. Each patient underwent LUS using a linear probe to determine total B-line score, total positive chest areas with ≥5 B-lines, and pleural line abnormalities; HRCT was scored by the Warrick system, and spirometry measured forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1). There was a substantial correlation (r=0.75, p<0.001) between the Total B-line score (mean 39.3±15.3) and the Warrick score (11.94±5.09) and the Warrick score and total positive chest area score (r=0.77, p<0.001). Notable unfavorable associations were observed between LUS B-line score and FVC (r=−0.75, p=0.00) and FEV1 (r=−0.73, p=0.00). LUS demonstrated sensitivity of 97.9% and diagnostic accuracy of 94.2% compared with HRCT, though specificity was moderate (60%). These findings indicate that LUS closely mirrors HRCT and spirometry in assessing ILD severity. Given its high sensitivity, safety profile, and accessibility, LUS may serve as a valuable adjunct for routine evaluation and follow-up of ILD patients, particularly where repeated HRCT is impractical. Further large-scale, prospective studies are required to validate standardized LUS scoring and establish its role in guiding ILD management.
Ethics Approval
The institutional ethical review board granted a waiver for ethical clearance for this study as no ethical issues were found (F.1/IEC/MAMC/70/5/2019/569).
References
- Devaraj A. Imaging: how to recognise idiopathic pulmonary fibrosis. Eur Respir Rev 2014;23:215-9. DOI: https://doi.org/10.1183/09059180.00001514
- Volpicelli G, Elbarbary M, Blaivas M, et al. International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med 2012;38:577-91. DOI: https://doi.org/10.1007/s00134-012-2513-4
- Raghu G, Collard HR, Egan JJ, et al. An official ATS/ ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis—evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824. DOI: https://doi.org/10.1164/rccm.2009-040GL
- Mohammadi A, Oshnoei S, Ghasemi-Rad M. Comparison of a new, modified lung ultrasonography technique with high-resolution CT in the diagnosis of the alveolo-interstitial syndrome of systemic scleroderma. Med Ultrason 2014;16:27-31. DOI: https://doi.org/10.11152/mu.2014.2066.161.am1so2
- Çakir Edis E, Hatipoğlu ON, Pamuk ÖN, et al. Effectiveness of thoracic ultrasonography in the evaluation of the severity of pulmonary involvement in patients with systemic sclerosis. Arch Rheumatol 2016;31:364-70. DOI: https://doi.org/10.5606/ArchRheumatol.2016.5849
- Tardella M, Gutierrez M, Salaffi F, et al. Ultrasound B-lines in the evaluation of interstitial lung disease in patients with systemic sclerosis. Medicine 2018;97:18. DOI: https://doi.org/10.1097/MD.0000000000010566
- Schurawitzki H, Stiglbauer R, Graninger W, et al. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 1990;176:755-9. DOI: https://doi.org/10.1148/radiology.176.3.2389033
- Picano E, Matucci-Cerinic M. Unnecessary radiation exposure from medical imaging in the rheumatology patient. Rheumatology 2011;50:1537-9. DOI: https://doi.org/10.1093/rheumatology/keq412
- Barskova T, Gargani L, Guiducci S, et al. Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. Ann Rheum Dis 2013;72:390-5. DOI: https://doi.org/10.1136/annrheumdis-2011-201072
- Cogliati C, Antivalle M, Torzillo D, et al. Standard and pocket-Size lung ultrasound devices can detect interstitial lung disease in rheumatoid arthritis patients. Rheumatology 2014;53:1497-503. DOI: https://doi.org/10.1093/rheumatology/keu033
- Vizioli L, Ciccarese F, Forti P, et al. Integrated use of lung ultrasound and chest x-ray in the detection of interstitial lung disease. Respiration 2017;93:15-22. DOI: https://doi.org/10.1159/000452225
- Asano M, Watanabe H, Sato K, et al. Validity of ultrasound lung comets for assessment of the severity of interstitial pneumonia. J Ultrasound Med 2018;37:1523-31. DOI: https://doi.org/10.1002/jum.14497
- Fessi R, Ourari B, ben Amar J, et al. High-resolution computed tomography fibrosis score and pulmonary function tests in interstitial lung disease: Is there any correlation? Eur Respir J Suppl 2018;52:PA2926. DOI: https://doi.org/10.1183/13993003.congress-2018.PA2926
- Man MA, Dantes E, Hancu BD, et al. Correlation between transthoracic lung ultrasound score and HRCT features in patients with interstitial lung diseases. J Clin Med 2019;8:1199. DOI: https://doi.org/10.3390/jcm8081199
- Picano E, Frassi F, Agricola E, et al. Ultrasound lung comets: a clinically useful sign of extravascular lung water. J Am Soc Echocardiogr 2006;19:356-63. DOI: https://doi.org/10.1016/j.echo.2005.05.019
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2026 The Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.